Bon Natural Life (BON) vs Ispire Technology (ISPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Ispire Technology is the larger company by market cap ($81.4 million vs $9.5 million), about 8.6 times the size. On valuation, Bon Natural Life trades at a lower forward P/E (2.0x vs 70.5x for Ispire Technology).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BON | ISPR |
|---|---|---|
| Share price | $1.16 | $1.41 |
| Market cap | $9.48M | $81.43M |
| 1-day change | -0.85% | +6.02% |
| YTD return | — | -49.64% |
| 1-year return | — | -38.96% |
| Forward P/E | 2.00 | 70.50 |
| EPS (TTM) | $-2.79 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.34 | $3.87 |
| 52-week low | $0.95 | $1.01 |
| Distance from 52-week high | -50.43% | -63.57% |
| Average volume | 8.04K | 35.70K |
| Shares outstanding | 6.13M | 57.75M |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Ispire Technology is about 8.6 times larger than Bon Natural Life by market value ($81.43M vs $9.48M).
BON vs ISPR FAQ
Which is bigger, Bon Natural Life or Ispire Technology?
Ispire Technology (ISPR) is larger, with a market capitalization of $81.43M compared with $9.48M for Bon Natural Life (BON).
Are Bon Natural Life and Ispire Technology in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.